|
Mahamaya Lifesciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
280.39 Cr.
|
P/BV
|
4.74
|
Book Value (Rs.)
|
25.27
|
|
52 Week High/Low (Rs.)
|
122/111
|
FV/ML
|
10/1200
|
P/E(X)
|
21.66
|
|
Bookclosure
|
|
EPS (Rs.)
|
5.53
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 |
| | | | |
| PER SHARE RATIOS | | | |
| | | | |
| Basic EPS (Rs.) | 7.60 | 3.26 | 2.34 |
| Diluted EPS (Rs.) | 7.60 | 3.26 | 2.34 |
| Cash EPS (Rs.) | 8.28 | 53.65 | 40.22 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 27.82 | 197.46 | 155.67 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 27.82 | 197.46 | 155.67 |
| Revenue From Operations / Share (Rs.) | 148.68 | 1293.81 | 1097.66 |
| PBDIT / Share (Rs.) | 14.61 | 116.13 | 73.83 |
| PBIT / Share (Rs.) | 13.61 | 104.27 | 63.65 |
| PBT / Share (Rs.) | 9.77 | 56.99 | 40.81 |
| Net Profit / Share (Rs.) | 7.29 | 41.79 | 30.03 |
| NP After MI And SOA / Share (Rs.) | 7.29 | 41.79 | 30.03 |
| | | | |
| PROFITABILITY RATIOS | | | |
| | | | |
| PBDIT Margin (%) | 9.82 | 8.97 | 6.72 |
| PBIT Margin (%) | 9.15 | 8.05 | 5.79 |
| PBT Margin (%) | 6.57 | 4.40 | 3.71 |
| Net Profit Margin (%) | 4.89 | 3.22 | 2.73 |
| NP After MI And SOA Margin (%) | 4.89 | 3.22 | 2.73 |
| Return on Networth / Equity (%) | 26.18 | 21.16 | 19.29 |
| Return on Capital Employeed (%) | 42.63 | 38.35 | 26.30 |
| Return On Assets (%) | 6.87 | 4.65 | 4.81 |
| Long Term Debt / Equity (X) | 0.12 | 0.34 | 0.52 |
| Total Debt / Equity (X) | 1.18 | 2.22 | 1.25 |
| Asset Turnover Ratio (%) | 1.76 | 1.70 | 0.00 |
| | | | |
| LIQUIDITY RATIOS | | | |
| | | | |
| Current Ratio (X) | 1.19 | 1.12 | 1.13 |
| Quick Ratio (X) | 0.42 | 0.46 | 0.40 |
| Inventory Turnover Ratio (X) | 3.49 | 3.77 | 0.00 |
| | | | |
| COVERAGE RATIOS | | | |
| | | | |
| Interest Coverage Ratio (%) | 3.80 | 2.46 | 3.23 |
| Interest Coverage Ratio (Post Tax) (%) | 2.90 | 1.88 | 2.31 |
